Prognostic Factors of Patients With ADHF

Chongqing Medical University

Status: Completed

Conditions: Acute Decompensated Heart Failure

Treatments: Other: elevated monocyte count

Study type: Observational

Funder types: Other

Identifiers

NCT04390919

2020-05-04

Details and patient eligibility

About

To explore the prognostic indicators for patients with ADHF

Full description

According to ESC Guidelines for the diagnosis of acute heart failure 2008, patients with ADHF were diagnosed, and their medical history, laboratory examination and treatment plan were retrospectively analyzed, and the patients were followed up for 1 year. The 1-year outcomes of patients were analyzed to explore the prognostic indicators for patients with ADHF

Enrollment: 362 patients

Sex: All

Ages: 18 to 94 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with ADHF diagnosed according to ESC Guidelines for the diagnosis of acute heart failure 2008

Exclusion criteria

• disorders of the hematopoietic system, history of cancer and/or previous treatment with chemotherapy, the infection caused by various pathogens, chronic inflammatory conditions, glucocorticoid therapy and/or histories of glucocorticoid use 3 months before the admission and acute myocardial infarction or coronary revascularization within the past 6 months. Also, patients who did not have a differential WBC count or who were lost to follow-up were excluded.

Trial design

362 participants in 2 patient groups

high group

Description:

high group: monocyte count≥0.445×10\*9 cells/L

Treatment:

Other: elevated monocyte count

low group

Description:

low group: monocyte count\<0.445×10\*9 cells/L;